SMTI — Sanara Medtech Balance Sheet
0.000.00%
- $158.04m
- $187.42m
- $103.12m
Annual balance sheet for Sanara Medtech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 18.7 | 8.96 | 5.15 | 15.9 | 16.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.99 | 7 | 8.53 | 13.6 | 12 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 24.6 | 20.6 | 19 | 33.3 | 33.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.04 | 2.22 | 3.25 | 1.88 | 2.53 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 36.4 | 61 | 73.9 | 88.1 | 72.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.02 | 12.8 | 13.8 | 15.3 | 18.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.76 | 19.2 | 29 | 48.7 | 67 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 30.6 | 41.8 | 44.8 | 39.4 | 5.94 |
| Total Liabilities & Shareholders' Equity | 36.4 | 61 | 73.9 | 88.1 | 72.9 |
| Total Common Shares Outstanding |